27.01.2015 Views

AGES XXIII Annual Scientific Meeting 2013 Abstracts & Program

AGES XXIII Annual Scientific Meeting 2013 Abstracts & Program

AGES XXIII Annual Scientific Meeting 2013 Abstracts & Program

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

The Pelvis in Pain<br />

Digital Communications<br />

Endometriosis and Beyond<br />

Free COMMUNICATIONS / DIGITAL<br />

COMMUNICATIONS SESSION<br />

Submucous fibroids – a series of hysteroscopic<br />

morcellation<br />

Nesbitt-Hawes EM, Sgroi J, Abbott JA<br />

OBJECTIVE: To report surgical outcomes for women having<br />

submucous myomas treated with the Myosure hysteroscopic<br />

morcellator.<br />

METHODS: A prospective, observational study was<br />

performed. Nineteen women who were scheduled for<br />

hysteroscopic resection of submucous myomas were<br />

identified as candidates to be treated with the Myosure<br />

device. Demographic and pre-operative data were obtained<br />

including ultrasound characteristics of the myomas. The<br />

morcellator was used according to the manufacturer’s<br />

instructions, including continuous, electronic fluid<br />

monitoring. Intraoperative data were collected and analysed.<br />

RESULTS: Between July and December 2012, there were<br />

22 cases of myoma morcellation at the Royal Hospital for<br />

Women and Prince of Wales Private Hospital. There was<br />

agreement between the ultrasound and hysteroscopic<br />

assessment of the myoma in 9/22 (41%) cases. 10/22 (45%)<br />

were type 0, 10/22 (45%) were type 1 and 2/22 (9%) were<br />

type 2 myomas, with a mean diameter of 26mm (SD 12-<br />

39mm). The mean cutting time was 5 minutes and 3 seconds<br />

and the saline deficit 1222mL. The pathology was removed<br />

completely in 16/22 (73%) of the cases, with 2/22 (9%)<br />

requiring further treatment at the time of the first surgery<br />

and 3/22 (14%) requiring a second surgery. There were no<br />

intra-operative or post-operative complications.<br />

CONCLUSIONS: The Myosure hysteroscopic morcellator is<br />

effective in the treatment of submucous myomas including<br />

up to 50mm diameter. Difficulties with the morcellator<br />

seemed to be associated with calcified myomas and may<br />

relate to the calibre of the device.<br />

AUTHOR AFFILIATION: E. M. Nesbitt-Hawes, J. Sgroi, J. A.<br />

Abbott; Royal Hospital for Women, Randwick, New South<br />

Wales, Australia.<br />

Free COMMUNICATIONS / DIGITAL<br />

COMMUNICATIONS SESSION<br />

Thinking outside the box. Women’s experience of<br />

living with endometriosis: a qualitative study<br />

Moradi M, Parker M, Lopez V, Sneddon A, Phillips<br />

C, Ellwood D<br />

OBJECTIVES: Endometriosis is a chronic disease defined<br />

as the presence of endometrial tissue outside the uterus and<br />

is characterised by period and pelvic pain for many women.<br />

However QoL research has suggested that the impact and<br />

experience of living with endometriosis extends beyond the<br />

pelvis. 1 The aim of this study was to explore women’s long<br />

term experiences of living with endometriosis, the impact of<br />

disease on all aspects of their lives and whether impact varies<br />

across age groups.<br />

METHOD: A qualitative descriptive design with a<br />

phenomenological framework was used. Ten Semistructured,<br />

in-depth, face to face focus groups were run for<br />

three age groups (16-24, 25-34, 35 plus years). A sample<br />

of 35 Australian women with a laparoscopic diagnosis of<br />

endometriosis was purposefully recruited, including 23<br />

women from the Endometriosis Centre at The Canberra<br />

Hospital and 12 women who had not attended the Centre.<br />

Thematic analysis was used to analyze the data transcribed<br />

using NVivo 9 software.<br />

RESULTS: 10 focus group discussions of 2-2.5 hours were<br />

conducted. The age of participants ranged from 17-53 years.<br />

Average delayed diagnosis was 8.1 years and women had<br />

experienced symptoms for a range of 2 to 40 years.<br />

Common symptoms experienced were: period pain,<br />

dyspareunia, heavy bleeding, irregular bleeding, and infertility.<br />

20 final themes emerged from data analysis; six themes<br />

with regard to experiences of living with endometriosis and<br />

fourteen themes with regard to the impact of endometriosis<br />

on women’s lives. Most participants had experienced<br />

prolonged and severe pain, delayed diagnosis, various<br />

treatments, several surgeries and recurrence of disease.<br />

The majority of women reported that endometriosis had<br />

a high impact on their life with the four most commonly<br />

highlighted areas for all age groups being marital/sexual<br />

relationship, social life, physical and psychological although<br />

order of priority varied. However some differences in<br />

the next most highlighted areas were noted, education in<br />

the young women (16-24 years), life opportunities and<br />

employment for the 25-34 year olds; and financial impact for<br />

the 35 plus age group.<br />

CONCLUSION: Greater awareness of the negative<br />

impact of endometriosis highlights the importance health<br />

professionals play in best practice disease management that<br />

extends beyond the pelvis to reduce the negative impact<br />

of disease across the menstrual lifespan. For example,<br />

achieving a fulfilling sex life despite endometriosis may<br />

improve relationships and ensuring that young women with<br />

endometriosis are supported to complete their education may<br />

help maximize future employment and life opportunities.<br />

REFERENCE:<br />

1. Gao X. et al. Health-related quality of life burden of<br />

women with endometriosis: a literature review. Current<br />

Medical Research and Opinion 2006; 22(9): 1787- 1797<br />

KEYWORDS: Endometriosis, qualitative research, quality of<br />

life, impact<br />

AUTHOR AFFILIATIONS: M. Moradi 1 , M. Parker 2 , V.<br />

Lopez 3 , A. Sneddon 4 , C. Phillips 3 , D. Ellwood 3 ; 1. Australian

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!